Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.85
-0.06-2.06%
At close: -
$2.78
-0.07-2.46%
After Hours: 5:25 PM EDT
Comments
Loading...
Alto Neuroscience Analyst Ratings and Price Targets | NYSE:ANRO | Benzinga
Alto Neuroscience Inc has a consensus price target of $18.29 based on the ratings of 7 analysts. The high is $43 issued by Rodman & Renshaw on June 21, 2024. The low is $4 issued by Wedbush on May 15, 2025. The 3 most-recent analyst ratings were released by Wedbush, HC Wainwright & Co., and Jones Trading on May 15, 2025, April 7, 2025, and December 16, 2024, respectively. With an average price target of $10.67 between Wedbush, HC Wainwright & Co., and Jones Trading, there's an implied 274.27% upside for Alto Neuroscience Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wedbush
HC Wainwright & Co.
Jones Trading
Stifel
Baird
1calculated from analyst ratings
Analyst Ratings for Alto Neuroscience
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2025 | Buy Now | 40.35% | Wedbush | Laura Chico45% | $4 → $4 | Reiterates | Neutral → Neutral | Get Alert |
| 04/07/2025 | Buy Now | 250.88% | HC Wainwright & Co. | Patrick Trucchio46% | → $10 | Initiates | → Buy | Get Alert |
| 12/16/2024 | Buy Now | 531.58% | Jones Trading | Justin Walsh39% | → $18 | Initiates | → Buy | Get Alert |
| 11/13/2024 | Buy Now | 250.88% | Stifel | Paul Matteis43% | $32 → $10 | Maintains | Buy | Get Alert |
| 10/23/2024 | Buy Now | 40.35% | Wedbush | Laura Chico45% | $29 → $4 | Downgrade | Outperform → Neutral | Get Alert |
| 10/23/2024 | Buy Now | 250.88% | Baird | Brian Skorney57% | $32 → $10 | Maintains | Outperform | Get Alert |
| 09/10/2024 | Buy Now | 917.54% | Wedbush | Laura Chico45% | $29 → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 09/03/2024 | Buy Now | 917.54% | Wedbush | Laura Chico45% | → $29 | Initiates | → Outperform | Get Alert |
| 06/21/2024 | Buy Now | 1408.77% | Rodman & Renshaw | Elemer Piros54% | → $43 | Initiates | → Buy | Get Alert |
| 03/25/2024 | Buy Now | 1022.81% | Stifel | Paul Matteis43% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2024 | Buy Now | 1022.81% | Stifel | Paul Matteis43% | → $32 | Initiates | → Buy | Get Alert |
| 02/27/2024 | Buy Now | 1057.89% | Jefferies | Andrew Tsai25% | → $33 | Initiates | → Buy | Get Alert |
| 02/27/2024 | Buy Now | 1022.81% | Baird | Brian Skorney57% | → $32 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Alto Neuroscience (ANRO) stock?
The latest price target for Alto Neuroscience (NYSE:ANRO) was reported by Wedbush on May 15, 2025. The analyst firm set a price target for $4.00 expecting ANRO to rise to within 12 months (a possible 43.88% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alto Neuroscience (ANRO)?
The latest analyst rating for Alto Neuroscience (NYSE:ANRO) was provided by Wedbush, and Alto Neuroscience reiterated their neutral rating.
When was the last upgrade for Alto Neuroscience (ANRO)?
There is no last upgrade for Alto Neuroscience
When was the last downgrade for Alto Neuroscience (ANRO)?
The last downgrade for Alto Neuroscience Inc happened on October 23, 2024 when Wedbush changed their price target from $29 to $4 for Alto Neuroscience Inc.
When is the next analyst rating going to be posted or updated for Alto Neuroscience (ANRO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alto Neuroscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alto Neuroscience was filed on May 15, 2025 so you should expect the next rating to be made available sometime around May 15, 2026.
Is the Analyst Rating Alto Neuroscience (ANRO) correct?
While ratings are subjective and will change, the latest Alto Neuroscience (ANRO) rating was a reiterated with a price target of $4.00 to $4.00. The current price Alto Neuroscience (ANRO) is trading at is $2.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
